Effect of docanol on the hemostatic and fibrinolytic systems and lipid spectrum in patients wish coronary heart disease in relation to baseline fibrinolytic activity

被引:0
|
作者
Lyutova, LV [1 ]
Karabasova, MA [1 ]
Andreyenko, GV [1 ]
Panchenko, VM [1 ]
Isayeva, VA [1 ]
Sorokaletova, SM [1 ]
Yershova, AA [1 ]
机构
[1] MOSCOW MV LOMONOSOV STATE UNIV,DEPT BIOL,MOSCOW,RUSSIA
来源
VOPROSY MEDITSINSKOI KHIMII | 1996年 / 42卷 / 01期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Forty patients with coronary heart disease (CHD) concurrent with hyperlipidemia were divided into 2 groups according to the baseline fibrinolytic activity. The group with the depressed fibrinolytic system displayed the highest atherogenicity index and levels of cholesterol, low and very low density lipoprotein cholesterol and half levels of high density lipoproteins. After 45-day ingestion of docanol, a new Russian food additive containing docosahexanois and eicosapentaenoic acids there were positive changes in the lipid spectrum in the both groups. The fibrinolytic changes were heterodirectional: activator and plasminic activities increased in the group of fibrinolytic depression while in the group of baseline normal fibrinolysis the activity of plasminogen activator fell.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
  • [1] Effect of puerarin on fibrinolytic activity and lipid peroxide in patients with coronary heart disease
    Jiangbin Chen
    Jiali Xu
    Jianjun Li
    Congxin Huang
    Qizhu Tang
    Jinming Wang
    Gengshan Li
    [J]. Chinese Journal of Integrated Traditional and Western Medicine, 2000, 6 (1): : 61 - 61
  • [2] Effect of Puerarin on Fibrinolytic Activity and Lipid Peroxide in Patients with Coronary Heart Disease
    陈江斌
    许家俐
    李建军
    黄从新
    唐其柱
    王晋明
    李庚山
    [J]. Chinese Journal of Integrative Medicine, 2000, (01) : 61 - 61
  • [3] FIBRINOLYTIC ACTIVITY IN CORONARY HEART DISEASE
    Yao Sheng-kun
    Chen Zai-jia
    Tao Shou-qi
    [J]. CHINESE MEDICAL JOURNAL, 1989, (09)
  • [4] Influence of molsidomine on the fibrinolytic capacity and other hemostatic parameters in patients with coronary heart disease
    Schmutzler, H
    Stork, T
    Rocker, L
    [J]. HERZ KREISLAUF, 1995, 27 (12): : 423 - 427
  • [5] FIBRINOLYTIC-ACTIVITY IN CORONARY HEART-DISEASE
    YAO, SK
    CHEN, ZJ
    TAO, SQ
    [J]. CHINESE MEDICAL JOURNAL, 1989, 102 (09) : 660 - 663
  • [6] Fibrinolytic activity in patients with ischaemic heart disease
    MandicRadic, S
    Dincic, D
    Subota, V
    Jovic, P
    [J]. JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1996, 15 (04): : 304 - 304
  • [7] EFFECT OF THE INGESTION OF VARIOUS FATS ON THE FIBRINOLYTIC ACTIVITY IN NORMAL SUBJECTS AND PATIENTS WITH CORONARY HEART DISEASE
    GAJEWSKI, J
    [J]. JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1961, 1 (03): : 222 - 228
  • [8] THE EFFECT OF ATROMID ON FIBRINOLYTIC ACTIVITY OF PATIENTS WITH ISCHAEMIC HEART DISEASE AND HYPERCHOLESTEROLAEMIA
    SRIVASTAVA, SC
    SMITH, MJ
    DEWAR, HA
    [J]. JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1963, 3 (5-6): : 640 - 647
  • [9] DEFECTIVE FIBRINOLYTIC-ACTIVITY IN CORONARY HEART-DISEASE
    WALKER, ID
    DAVIDSON, JF
    HUTTON, I
    [J]. THROMBOSIS AND HAEMOSTASIS, 1977, 38 (01) : 45 - 45
  • [10] FIBRINOLYTIC-ACTIVITY, OBESITY, AND CORONARY HEART-DISEASE
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 224 (09): : 1288 - 1288